NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
 

CME Course Description

Login to view
Course Activities.



Speaker
Kevin L. Thomas, MD

Associate Professor of Medicine
Duke University Medical Center
Division of Clinical Cardiac Electrophysiology
Duke Clinical Research Institute
Durham, NC

Registration for this expired course is open for zero credits.

Title:
Applying the Latest Advances and Evidence of Clinical Outcomes to Individualize Heart Failure Treatment
Activity/Course #:
ACME117


Cost:
Free
Release/Start Date:
Nov 01 2016
Expiration Date:
Oct 31 2017
Topics:
Cardiovascular
Target Audience:
Primary Care Providers
Medium/Method:
Webcast
Estimated Time To Complete CME Activity:
1.0 Hour
Hardware/Software Requirements:
Internet Explorer, Firefox and Safari browsers (Chrome not supported at this time)
Credit(s):
0
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2016 conference. The topic of this webcast is Applying the Latest Advances and Evidence of Clinical Outcomes to Individualize Heart Failure Treatment and features Kevin L. Thomas, MD.
Learning Objective(s):
After completing this program participants should be able to:
  1. Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment
  2. Recognize the importance of heart rate in cardiovascular risk of heart failure
  3. Utilize the most recent clinical evidence to inform their decisions for the management of heart failure
  4. Identify approaches to facilitate early recognition and optimization of heart failure management


This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hours of continuing education (which includes 0.50 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Kevin L. Thomas, MD, Speaker, has the following relationship to disclose: Consultant - BMS, Pfizer.

Ola Akinboboye, MD, MPH, MBA, FACP, FACC, FASNC, FSCCT, FAHA, DABSM, Planning Committee, has the following relationship to disclose: As per the American Board of Internal Medicine, Dr. Akinboboye will not present content that will have any direct link with the Cardiovascular Board Exam.

Phillip B. Duncan, MD, Planning Committee, has the following relationship to disclose: Advisory Board - Arbor; Speakers Bureau - Novartis.

Keith Ferdinand, MD, FACC, FAHA, Planning Committee, has the following relationship to disclose: Consultant - Boehringer Ingelheim, Sanofi, Amgen, Eli Lilly.

Icilma V. Fergus, MD, FACC, Planning Committee, has no relationships to disclose.

Elizabeth Ofili, MD, MPH, FACC, Planning Committee, has the following relationship to disclose: Grant/Research support - National Institute of Health; Consultant/Advisory Board Bristol-Myers Squibb, Novartis, Arbor, Merck & Co., Janssen Research and Development.

Anekwe Onwuanyi, MD, Planning Committee, has the following relationship to disclose: Speaker - Novartis.

Priscilla Pemu, MD, MSCR, FACP, Planning Committee, has the following relationship to disclose: Employee Morehouse School of Medicine, Piedmont Medical Care Corporation.

David Smith, MD, Planning Committee, has the following relationship to disclose: Speaker - Arbor, CardioDx.

Mark Thompson, MD, Planning Committee, has the following relationship to disclose: Speaker/Training - Novartis.

Karol E. Watson, MD, PhD, Planning Committee, has the following relationship to disclose: Consultant Amgen, GSK, Merck, Quest.

Gregg Sherman, MD
, Course Director, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by is supported by educational funding provided by Amgen.